The Medicine Maker

Deepen your insight into the #pharma and #biopharma field! 💊 Are you passionate about the (bio)pharmaceutical industry? Do you want to stay up-to-date with the latest topics, trends, and technologies driving the industry forward? 🧪 Sign up for The Medicine Maker's newsletter today: https://bit.ly/3Vu15lw Join our community of industry professionals and enthusiasts now! #PharmaceuticalIndustry #Biotechnology

Have you noticed a shortage of skilled individuals entering the #pharmaindustry? Here, experts from Sterling Pharma Solutions give their views on recruitment – and the need for the right programs for success. https://bit.ly/3VAVAD9

What’s all this talk of #cancer vaccines? We find out how they work – and how #mRNA has boosted the field – with the help of five experts. Read Part 1 here: https://bit.ly/3L7QN5H

Diethylene glycol & ethylene glycol are toxic when ingested above acceptable limits - and they’ve been found in cough medicines for children. Here's how Chaitanya Koduri, Director of International Government and Regulatory Engagement at the US Pharmacopeia, is reacting. 👉 https://bit.ly/3wumu5I

"But it worked" Dr. Carl June, the "father of CAR-T cell therapy", in his own words to The Medicine Maker upon receiving the Advanced Therapies Lifetime Achievement Award 🏆 "No one could have predicted what has happened in CAR T – for many reasons. For one thing, it actually worked a lot better in our initial trials in humans than it had worked in mice. [] Also, back in the 1990s, there were only about five labs working on CAR T cells. There was no pharmaceutical industry involvement back then, and for the academics (including my own lab) that were working on the topic, it was more of an academic thought experiment: Could you redirect a T cell and use it to treat cancer? We weren’t necessarily thinking it would or could ever be commercialized, but it worked. Back then, there was no cell therapy industry – but now there is. And the statistics are amazing." University of Pennsylvania School of Medicine #celltherapy #curecancer #legend 👇 Link ▶ https://lnkd.in/ejxvyeBX

So much progress is being made in the #cancervaccine space. Thanks Stephanie Vine (formerly Sutton) and The Medicine Maker for highlighting the 5 different approaches from CureVac, Transimmune AG, Ultimovacs ASA, Candel Therapeutics and OSE Immunotherapeutics. Looking forward to reading the next parts in the series! #mRNA #oncology https://lnkd.in/eac6aZDA

Nominations for the 2024 Innovation Awards are officially open! 📣 The Medicine Maker Innovation Awards recognize breakthrough technology released onto the market over the course of 2024. New equipment, software, instruments, formulation technology, and other innovations from any area of #drugdevelopment and #drugmanufacture launched so far this year are eligible – and there's still half a year of potential innovation ahead of us! Simply take 5 minutes to fill out our nomination form today! 👉 https://bit.ly/3RcsUxw

Julian Northen, Solid State Manager at Onyx Scientific, shares his tips for successful small molecules drugs development. 👉 https://bit.ly/4bhhhwf

🕹️ After media headlines reported that Nintendo’s Super Mario Odyssey could treat depression, we spoke to the researcher involved - Moritz Bergmann - to understand the true results of the study. 🔎 https://bit.ly/3T6Jf6T

How much change can patients cope with when it comes to their #drugdelivery device? According to Alex Fong, Head of Insight at Owen Mumford Pharmaceutical Services, we need to step away from assumptions on device interchangeability and find out what patients really want. Read more here: https://bit.ly/3zjTTkA